Superresolution Ultrasound Challenges Prevailing Understanding of Nerve Blood Flow in Diabetic Patients

Recent research suggests that superresolution ultrasound (US) technology may redefine the detection of diabetic peripheral neuropathy (DPN) by uncovering intricate microvascular changes in the tibial nerve. The study, published in Radiology and led by Dr Fang Liu of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, identifies increased nerve blood flow and vascularity in patients with DPN and ulcers. These results contest the conventional belief that DPN primarily results from reduced blood flow.

Dr Levon N. Nazarian, a radiology professor at the Hospital of the University of Pennsylvania, highlights the potential of this superresolution US as a diagnostic tool, indicating significant clinical implications if proven accurate and reliable.

DPN is prevalent among individuals with diabetes, leading to symptoms such as numbness, ulcers, infections, and skeletal damage. While microvascular changes are acknowledged contributors to DPN, their extent remains debated due to imaging resolution constraints. Dr Liu’s team advocates for superresolution US to depict microvascular networks at a 10-µm resolution, offering concurrent structural and functional vessel insights.

Traditionally, nerve US evaluates abnormalities based on alterations in size, shape, and texture, without assessing functionality—a domain typically reserved for electromyography (EMG). However, this study enables radiologists to infer nerve function from US-depicted microcirculation.

The study assessed 100 participants: diabetics with DPN and lower limb ulcers, diabetics without DPN, and non-diabetic controls. Through microbubble contrast-enhanced imaging, the research team observed heightened blood flow in the tibial microvasculature among neuropathy and ulcer patients, defying existing models that predict reduced nerve perfusion.

Dr Nazarian acknowledges the method’s promise but notes barriers to its broader clinical adoption. Participants with ulcers and neuropathy typically also had peripheral artery disease (PAD) and were older, elements to be resolved in future studies. He also cites logistical impediments, such as the advanced imaging technology and contrast agents required, which are not readily available to all practitioners.

While there are hurdles to overcome, including technical learning curves and financial considerations, Dr Nazarian foresees superresolution US facilitating earlier DPN diagnosis and potentially expanding its application to assorted neuropathies. This pioneering imaging method could thus bridge the gap between morphological and functional nerve imaging.